Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Medical Technology
- Funding URL
- View Funding Page
Company Info
- Traction
- Clinical trials for CaverSTIM are underway in Australia, Brazil, and the United States, showing promising results.
- Company Description
- Comphya is a leader in medical technology that has developed CaverSTIM, the world's first implantable neuromodulator for erectile dysfunction. The device aims to restore erectile function in patients who do not respond to oral medications, utilizing an implantable pulse generator and electrodes to stimulate the necessary nerves.
- Market
- Erectile Dysfunction Treatment
- Location
-
Switzerland
Links